The results of a study on the effectiveness 37 and safety of treatment with vemurafenib and cytarabine/2-chloro-2′-deoxyadenosine combination in patients with Langerhans cell histiocytosis with &lt;i&gt;BRAFV600E&lt;/i&gt; mutation
Voprosy gematologii/onkologii i immunopatologii v pediatrii